FKFunda Korkmaz

Funda Korkmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Funda Korkmaz has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Erythroferrone Modulates Osteoblast-Osteoclast Crosstalk During Bone Remodeling

    by Pinanong Na-Phatthalung, Gabrielle van Caloen, Marina Planoutene, Anisa Azatovna Gumerova, Georgii Pevnev, Ronit Witztum, Eva Ingber, Leon Kautz, Farhath Sultana, Funda Korkmaz, et al.

    Erythroferrone (ERFE) secretion inhibits hepcidin expression by sequestering several bone morphogenetic protein (BMP) family members to increase iron availability for erythropoiesis. Recent evidence demonstrates that ERFE is also expressed in osteoblasts and osteoclasts and Erfe-/- mice display low-bone-mass arising from increased bone resorption despite a concomitant increase in bone formation. To mechanistically dissect how bone-derived ERFE exerts an osteoprotective effect, we first created Erfefl/fl mice, which were then crossed with Col2.3-Cre mice to generate osteoblast-selective Erfe mutants (or Erfefl/fl;Col2.3-Cre mice). We now demonstrate that ERFE derived from osteoblasts is not responsible for the decreased BMD noted in Erfe-/- mice, revealing enhanced BMD during anabolic stress in Erfefl/fl;Col2.3-Cre mice. Consistently, in contrast to global ERFE loss, osteoblast-selective ERFE loss does not increase osteoclasts in vivo. Furthermore, our results demonstrate that ERFE loss in osteoblasts induces osteoclast Erfe expression in co-culture experiments in vitro. Finally, the osteoclastogenesis gene program is induced in co-culture with osteoblasts only when ERFE is lost in osteoclasts. Taken together, our finding provide strong evidence of osteoclast-derived ERFE as a central osteoprotective regulator of bone mass, its loss resulting in net bone loss in Erfe-/- mice.

  • Open Access

    Sex-specific single transcript level atlas of vasopressin and its receptor (AVPR1a) in the mouse brain

    by Anisa Azatovna Gumerova, Georgii Pevnev, Funda Korkmaz, Uliana Cheliadinova, Guzel Burganova, Darya Vasilyeva, Liam Cullen, Orly Barak, Farhath Sultana, Weibin Zhou, et al.

    Vasopressin (AVP), a nonapeptide synthesized predominantly by magnocellular hypothalamic neurons, is conveyed to the posterior pituitary via the pituitary stalk, where AVP is secreted into the circulation. Known to regulate blood pressure and water homeostasis, it also modulates diverse social behaviors, such as pair bonding, social recognition, and cognition in mammals, including humans. Importantly, AVP modulates social behaviors in a sex-specific manner, perhaps due to sex differences in the distribution in the brain of AVP and its main receptor AVPR1a. There is a corpus of integrative studies for the expression of AVP and AVPR1a in various brain regions, and their functions in modulating central and peripheral actions. In order to purposefully address sexually dimorphic and novel roles of AVP on central and peripheral functions through its AVPR1a, we utilized RNAscope to map Avp and Avpr1a single transcript expression in the mouse brain. As the most comprehensive atlas of AVP and AVPR1a in the mouse brain, this compendium highlights the importance of newly identified AVP/AVPR1a neuronal nodes that may stimulate further functional studies.

  • Open Access

    Single transcript level atlas of oxytocin and the oxytocin receptor in the mouse brain

    by Vitaly Ryu, Anisa Azatovna Gumerova, Georgii Pevnev, Funda Korkmaz, Hasni Kannangara, Liam Cullen, Farhath Sultana, Ronit Witztum, Steven Lee Sims, Tal Frolinger, et al.

    Oxytocin (OXT), a primitive nonapeptide known to regulate reproduction and social behaviors, is synthesized primarily in the hypothalamus and is secreted via the hypophyseal-portal system of the posterior pituitary gland. In line with the premise that pituitary hormones, traditionally thought of as regulators of single targets, display an array of central and peripheral actions, we found that OXT directly affects bone and body composition. The effect of OXT on bone remodeling is physiologically relevant, as elevated OXT levels during pregnancy and lactation cause calcium mobilization from the maternal skeleton for intergenerational calcium transfer towards fetal bone mineralization. There is an equally large body of evidence that has established the presence of OXT receptors (OXTRs) in the brain through which central functions, such as social bonding, and peripheral functions, such as the regulation of body composition, are exerted. To purposefully address effects of OXT on the brain, we used RNAscope to map OXT and OXTR expression, at the single transcript level, in the whole female and male mouse brains. Identification of brain nuclei with the highest OXT and OXTR transcript density sheds further light on functional OXT nodes that could be further interrogated experimentally to define new physiologic circuitry.


  • Open Access

    Musculoskeletal and neurocognitive clinical significance of adult hypophosphatasia

    by Se-Min Kim, Funda Korkmaz, Steve Sims, Vitaly Ryu, Tony Yuen, Mone Zaidi


  • Faculty Opinions recommendation of Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals.

    by Mone Zaidi, Funda Korkmaz

    Alzheimer's disease (AD) is characterized by the deposition of amyloid plaques and neurofibrillary tau tangles in the brain. Alzheimer’s disease-related pathologic changes in the brain start years before symptom onset, which makes a clinical diagnosis in the early phase difficult. In recent years, several fluid biomarkers for AD have been developed to be able to diagnose AD before symptom onset, but their pathological correlates to predict disease development have not been fully clarified. These biomarkers might detect pathologic changes in the brain during the preclinical stage of the disease and will enable intervention prior to widespread neural and synaptic loss. This article showed that an N-terminal fragment of the tau protein (NT1) measured in plasma is a potential predictor of future cognitive decline, neurodegeneration, tau accumulation, and the development of mild cognitive impairment or AD in the preclinical stage of the disease.

  • Faculty Opinions recommendation of Intermittent fasting protects against Alzheimer’s disease in mice by altering metabolism through remodeling of the gut microbiota.

    by Mone Zaidi, Funda Korkmaz

    Disruption of the brain-gut-microbiota axis may significantly contribute to the pathogenesis of neurodegenerative disorders {1}. Alzheimer’s disease (AD) is characterized by a gradual and progressive decline in cognitive functions and the presence of specific neuron and synapse loss in addition to senile plaques and neurofibrillary tangles that primarily affect older adults. Although aging is the major risk factor for AD, the dietary restriction can impede the aging process in the brain. Much research showed that dietary modifications such as intermittent fasting (IF) improve mood and cognition and protect against excitotoxic degeneration in animal models of AD. The mechanism by which neuronal networks adapt to IF and how such adaptations impact the neuropathological process are unknown {2}. The authors highlight that IF improves cognitive function in the 5xFAD mice model through the brain-gut-microbiota axis. They showed that sarcosine (Sar) and dimethylglycine (DMG), as key amino acids in the IF induced reduction in of AD symptoms, providing opportunities for new therapeutic approaches for further AD treatment.

  • Open Access

    FSH-blocking therapeutic for osteoporosis

    by Sakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, Funda Korkmaz, Damini Sant, Victoria DeMambro, Karthyayani Sudha, Ashley Padilla, Geoffrey Prevot, Jazz Munitz, et al.

    Pharmacological and genetic studies over the past decade have established the follicle-stimulating hormone (FSH) as an actionable target for diseases affecting millions, namely osteoporosis, obesity, and Alzheimer’s disease. Blocking FSH action prevents bone loss, fat gain, and neurodegeneration in mice. We recently developed a first-in-class, humanized, epitope-specific FSH-blocking antibody, MS-Hu6, with a KD of 7.52 nM. Using a Good Laboratory Practice (GLP)-compliant platform, we now report the efficacy of MS-Hu6 in preventing and treating osteoporosis in mice and parameters of acute safety in monkeys. Biodistribution studies using 89Zr-labeled, biotinylated or unconjugated MS-Hu6 in mice and monkeys showed localization to bone and bone marrow. The MS-Hu6 displayed a β phase t½ of 7.5 days (180 hr) in humanized Tg32 mice. We tested 217 variations of excipients using the protein thermal shift assay to generate a final formulation that rendered MS-Hu6 stable in solution upon freeze-thaw and at different temperatures, with minimal aggregation, and without self-, cross-, or hydrophobic interactions or appreciable binding to relevant human antigens. The MS-Hu6 showed the same level of “humanness” as human IgG1 in silico and was non-immunogenic in ELISpot assays for IL-2 and IFN-γ in human peripheral blood mononuclear cell cultures. We conclude that MS-Hu6 is efficacious, durable, and manufacturable, and is therefore poised for future human testing.


  • Faculty Opinions recommendation of Peripheral Aβ acts as a negative modulator of insulin secretion.

    by Mone Zaidi, Funda Korkmaz

    Alzheimer’s disease (AD) is characterized by a gradual and progressive decline in cognitive functions and the presence of specific neuron and synapse loss in addition to senile plaques and neurofibrillary tangles. Diabetes is a known risk factor for Alzheimer’s disease, but we do not yet exactly understand how cognitive decline and diabetes are connected. Hyperglycemia increases amyloid beta (Aβ) accumulation on brain lesions, exacerbates oxidative stress, neuroinflammation, and mitochondrial dysfunction, impairs neuronal integrity, and causes neurodegeneration {1,2}. These could be the potential working mechanisms underlying diabetes-related dementia. Here, the authors showed that peripheral tissues, including the pancreas, adipose tissues, skeletal muscles, and liver are the source of plasma Aβ. Peripheral Aβ suppressed the glucose-induced increase in the plasma insulin level. These findings provide a possible mechanism linking diabetes to AD and calls attention to how plasma Aβ levels are used in AD diagnosis.

  • Faculty Opinions recommendation of Alzheimer-like tau accumulation in dentate gyrus mossy cells induces spatial cognitive deficits by disrupting multiple memory-related signaling and inhibiting local neural circuit.

    by Mone Zaidi, Funda Korkmaz

    This article shows a novel mechanism of underlying hTau-induced cognitive deficits and provides potential molecular targets and new experimental models for studying tauopathies, including AD. Li et al. first showed that accumulation of the truncated hTau N368 in the dentate gyrus (DG) mossy cells of 3xTg-AD mice was correlated to the cognitive deficits. To explore whether the AD-like human tau (hTau) accumulation in mossy cells affects cognitive functions, unilateral and bilateral mossy cell-specific overexpression of full-length wild-type hTau and hTau N368 in vDG were induced by infusing hTau and hTau N368 overexpressing virus. These mice developed cognitive impairments with the mossy cell hTau accumulation; however, the mice overexpressing truncated hTau N368 developed more severe pathologies and a more rapid cognitive impairment.

  • Faculty Opinions recommendation of Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer's disease.

    by Mone Zaidi, Funda Korkmaz

    Alzheimer disease (AD) is the most common cause of dementia and one of the leading sources of morbidity and mortality in the aging population. As the world’s population increases in age, the number of people living with dementia grows, so age-related modifiable risk factors have been thought to be one of the most important risk factors for age-related, non-genetic AD. As published in The National Academy of Medicine and The Lancet reports on strategies for dementia prevention, dementia could be prevented by targeting cardiovascular (CV) risk factors such as diabetes, hyperlipidemia, hypertension, obesity, and physical activity. For this reason, AD can be prevented or delayed in progression by repurposing the drugs that have been used in CV disease, such as a statin. Studies show that statin therapy decreases the risk of developing of AD and improves cognitive function in AD patients {1,2}. In this study, Tong et al. showed age-related molecular changes in the dentate gyrus (DG) granule cells of APP mice and the role of the Wnt signaling pathway in Simvastatin’s protective effects on memory, as well as the hippocampal memory circuit and structure in adult APP mice.